Comparison of the use of physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments

Environmental Health Perspectives

Volumn 113, Issue 12, 2005, Pages 1666-1668

  Emond, Claude ^a,b,d   Michalek, Joel E ^c   Birnbaum, Linda S ^b   DeVito, Michael J ^b  

^a NATIONAL RESEARCH COUNCIL   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c AIR FORCE RESEARCH LABORATORY   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dioxin; Epidemiology; PBPK; Pharmacokinetic; Physiologically based pharmacokinetic model; Ranch hand; Risk assessment

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ADULT; ARTICLE; BIOLOGICAL MODEL; BLOOD SAMPLING; COHORT ANALYSIS; CONCENTRATION RESPONSE; EXCRETION; EXPOSURE; FEMALE; HUMAN; INTOXICATION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RODENT; TOXICOKINETICS; VOLUNTEER;

RODENTIA;

EID: 29144507001     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8016     Document Type: Article

References (19)

1. Abraham K, Krowke R, Neubert D. 1988. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Arch Toxicol 62:359-368.
2. Andersen ME, Mills JJ, Gargas ML, Kedderis L, Birnbaum LS, Neubert D, et al. 1993. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk Anal 13:25-36.
3. Aylward LL, Brunet RC, Carrier G, Hays SM, Cushing CA, Needham LL, et al. 2005. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol 15:51-65.
4. Carrier G, Brunet RC, Brodeur J. 1995a. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. Toxicol Appl Pharmacol 131:253-266.
5. Carrier G, Brunet RC, Brodeur J. 1995b. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofuranes in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs. Toxicol Appl Pharmacol 131:267-276.
6. Deurenberg P, Weststrate JA, Seidell JC. 1991. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 65:105-114.
7. Diliberto JJ, Burgin D, Birnbaum LS. 1997. Role of CYP1A2 in hepatic sequestration of dioxin: studies using CYP1A2 knock-out mice. Biochem Biophys Res Commun 236:431-433.
8. Diliberto JJ, Devito MJ, Ross DG, Birnbaum LS. 2001. Subchronic exposure of [3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: relationship of steady-state levels to disposition and metabolism. Toxicol Sci 61:241-255.
9. Emond C, Birnbaum LS, DeVito M. 2004. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. Toxicol Sci 80:115-133.
10. Geusau A, Schmaldienst S, Derfler K, Papke O, Abraham K. 2002. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: kinetics and trials to enhance elimination in two patients. Arch Toxicol 76:316-325.
11. Hakk H, Diliberto JJ. 2002. Comparison of overall metabolism of 2,3,7,8-TCDD in CYP1A2 (-/-) knockout and C57BL/6N parental strains on mice. Organohalogen Compounds 55:461-464.
12. Hooiveld M, Heederik DJ, Kogevinas M, Boffetta P, Needham LL, Patterson DG Jr, et al. 1998. Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols, and contaminants. Am J Epidemiol 147:891-901.
13. Kohn MC, Walker NJ, Kim AH, Portier CJ. 2001. Physiological modeling of a proposed mechanism of enzyme induction by TCDD. Toxicology 162:193-208.
14. Michalek JE, Ketchum NS, Tripathi RC. 2003. Diabetes mellitus and 2,3,7,8-tetrachlorodibenzo-p-dioxin elimination in veterans of Operation Ranch Hand. J Toxicol Environ Health A 66:211-221.
15. Michalek JE, Pirkle JL, Caudill SP, Tripathi RC, Patterson DG Jr, Needham LL. 1996. Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 10-year follow-up. J Toxicol Environ Health 47:209-220.
16. Michalek JE, Pirkle JL, Needham LL, Patterson DG, Caudill SP, Tripathi RC, et al. 2002. Pharmacokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso adults and veterans of operation Ranch Hand. J Expo Anal Environ Epidemiol 12:44-53.
17. Poiger H, Schlatter C. 1986. Pharmacokinetics of 2,3,7,8-TCDD in man. Chemosphere 15:1489-1494.
18. Schecter A, Gasiewicz TA. 2003. Dioxins and Health. 2nd ed. Hoboken, NJ:Wiley-Interscience.
19. Steenland K, Calvert G, Ketchum N, Michalek J. 2001. Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data. Occup Environ Med 58:641-648.